BeiGene Ltd ADR buy Morgan Stanley
Start price
29.08.23
/
50%
€198.00
Target price
29.08.24
€295.36
Performance (%)
-12.63%
End price
30.08.24
€173.00
Summary
This prediction ended on 30.08.24 with a price of €173.00. The price of BeiGene Ltd ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.63%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BeiGene Ltd ADR | -0.752% | -0.752% | 53.488% |
| iShares Core DAX® | 0.794% | 2.841% | 22.630% |
| iShares Nasdaq 100 | 0.016% | -0.939% | 6.943% |
| iShares Nikkei 225® | 0.309% | -0.648% | 13.619% |
| iShares S&P 500 | 0.181% | -0.442% | 4.692% |
Comments by Morgan_Stanley for this prediction
In the thread BeiGene Ltd ADR diskutieren
BeiGene, Ltd. (NASDAQ: BGNE) had its price target lowered by analysts at Morgan Stanley from $321.00 to $319.00. They now have an "overweight" rating on the stock.
Ratings data for BGNE provided by MarketBeat
In the thread Trading BeiGene Ltd ADR
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Morgan_Stanley for BeiGene Ltd ADR
BeiGene Ltd ADR
Start price
Target price
Perf. (%)
€192.00
03.12.24
03.12.24
€285.03
03.12.25
03.12.25
47.92%
04.12.25
04.12.25

